Hypha Labs (FUNI) Stock Price

Hypha Labs Price

OTC·CLOSED
0.00
​
Market closed

Over the last 11 years Hypha Labs grew revenue by 35.4% annually, reaching 2.70 M USD. For Hypha Labs, the net margin of -76.2% is down versus -58.2% a few years ago.

Hypha Labs stock price

Access this data via the Eulerpool API

Hypha Labs business model & stock analysis

DigiPath, Inc. is a service-oriented independent testing laboratory and data analytics company, which engages in the provision of cannabis testing, education, training, and news coverage. The company is headquartered in Las Vegas, Nevada and currently employs 17 full-time employees. The company went IPO on 2011-12-23. The Company’s cannabis testing business is operated through its subsidiary, Digipath Labs, Inc., which performs all cannabis related testing using FDA-compliant laboratory equipment and processes. The firm is a third-party independent testing laboratory facility for cannabis, cannabis infused products, hemp and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients and eventually all end users of cannabis and botanical products. Its Digipath Labs screens medicinal and recreational cannabis for harmful contaminants, including residual solvents, moisture, water activity, visual inspection, pesticides, heavy metals, biological toxins, such as aflatoxin and ocratoxins, and microbial contaminants.

Frequently asked questions about Hypha Labs

Converted at the current exchange rate, the Hypha Labs share trades at 0.00 EUR (0.00 USD).

The revenue cannot currently be calculated for Hypha Labs.

The profit cannot currently be calculated for Hypha Labs.

The P/E ratio cannot be calculated for Hypha Labs at the moment.

The P/S cannot be calculated for Hypha Labs currently.

The Eulerpool Quality Score for Hypha Labs is 2/10.

The ISIN of Hypha Labs is US2538252022. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Hypha Labs is FUNI. The ticker symbol is used to trade Hypha Labs shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website digipath.com
Currency
USD
Initial public offering
Dec 23, 2011
ISIN
US2538252022
Cusip
253825202
Market capitalization
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
1.33
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
679.02 %
Last updated Oct 10, 2026, 9:08 PM

Hypha Labs Peer Group

Hypha Labs Ticker

OTC · DIGPOTC · DIGP

Hypha Labs FIGI

DIGP:US · BBG002CLPBK1DIGP:PQ · BBG002CLPBZ5DIGP:UV · BBG002CLPC10

All fundamentals and in-depth analysis of Hypha Labs

Our stock analysis for Hypha Labs stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hypha Labs. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.